Skip to main content
Signal8

Fitzpatrick Jennifer

SEC insider (Form 3/4/5 filer). CIK 0002061851. CLO and Head of Program Mgmt. at Sionna Therapeutics, Inc. (SION). 12 reported Form 4/5 transactions since Sep 2024; latest on Sep 17, 2026. Located in WALTHAM, MA.

Companies Fitzpatrick Jennifer has filed insider reports for

  • Sionna Therapeutics, Inc. (SION): Officer, CLO and Head of Program Mgmt.
Fitzpatrick Jennifer profile photo

Fitzpatrick Jennifer

CIK: 0002061851

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (33.3%)

Position reduction

Option Exercises (M)4 (33.3%)

Derivative conversions

Awards (A)3 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (8.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Sionna Therapeutics, Inc. logo
SION

Sionna Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

  • Sionna Therapeutics, Inc. logo
    SION

    Sionna Therapeutics, Inc.

    Sep 17, 2026
    Award
    Direct
    28.1K shares-
  • Sionna Therapeutics, Inc. logo
    SION

    Sionna Therapeutics, Inc.

    Sep 17, 2026
    Disposition

    Non-Qualified Stock Option (right to buy)

    Direct
    103.1K shares-
  • Sionna Therapeutics, Inc. logo
    SION

    Sionna Therapeutics, Inc.

    Sep 17, 2026
    Award
    Direct
    28.1K shares-
  • Sionna Therapeutics, Inc. logo
    SION

    Sionna Therapeutics, Inc.

    Jul 6, 2026
    Exercise
    Direct
    10.3K shares at avg. $6.11$63K
  • Sionna Therapeutics, Inc. logo
    SION

    Sionna Therapeutics, Inc.

    Jul 6, 2026
    Sale
    Direct
    10.3K shares at avg. $43.60$447K
  • Sionna Therapeutics, Inc. logo
    SION

    Sionna Therapeutics, Inc.

    Mar 5, 2026
    Sale
    Direct
    10.3K shares at avg. $33.86$347K
  • Sionna Therapeutics, Inc. logo
    SION

    Sionna Therapeutics, Inc.

    Mar 5, 2026
    Exercise
    Direct
    10.3K shares at avg. $6.11$63K
  • Sionna Therapeutics, Inc. logo
    SION

    Sionna Therapeutics, Inc.

    Jan 2, 2026
    Award

    Non-Qualified Stock Option (right to buy)

    Direct
    103.1K shares-
  • Sionna Therapeutics, Inc. logo
    SION

    Sionna Therapeutics, Inc.

    Dec 5, 2025
    Sale
    Direct
    10.3K shares at avg. $40.52$415K
  • Sionna Therapeutics, Inc. logo
    SION

    Sionna Therapeutics, Inc.

    Dec 5, 2025
    Exercise
    Direct
    10.3K shares at avg. $6.11$63K

1-10 of 12